[go: up one dir, main page]

CN1080863A - A kind of anti-alcoholic health care medicinal composition - Google Patents

A kind of anti-alcoholic health care medicinal composition Download PDF

Info

Publication number
CN1080863A
CN1080863A CN 93107382 CN93107382A CN1080863A CN 1080863 A CN1080863 A CN 1080863A CN 93107382 CN93107382 CN 93107382 CN 93107382 A CN93107382 A CN 93107382A CN 1080863 A CN1080863 A CN 1080863A
Authority
CN
China
Prior art keywords
add
preparation
ginseng stem
leaf
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 93107382
Other languages
Chinese (zh)
Inventor
谷黎红
裴玉萍
陈英杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHENYANG PHARMACY COLLEGE
Original Assignee
SHENYANG PHARMACY COLLEGE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHENYANG PHARMACY COLLEGE filed Critical SHENYANG PHARMACY COLLEGE
Priority to CN 93107382 priority Critical patent/CN1080863A/en
Publication of CN1080863A publication Critical patent/CN1080863A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明公开了一种解酒的药物组合物,它由葛 花、青皮和人参茎叶皂甙组成,具有解酒保健功效,可 以制成胶囊剂、片剂、冲剂、茶剂、口服液。The invention discloses a medicinal composition for hangover, which consists of kudzu Composed of flowers, green bark and ginseng stem and leaf saponins, it has the effect of hangover health care, and can To make capsules, tablets, granules, teas, oral liquids.

Description

本发明是一种解酒的药物,它是一种以中草药为原料,经特定加工工艺制成的中药制剂,具有解酒,保健功效,属于中药制剂领域。The invention relates to a medicine for hangover, which is a traditional Chinese medicine preparation made by using Chinese herbal medicine as a raw material through a specific processing technology.

饮酒是多数的人一种嗜好,但是过量饮酒会对人体带来严重的损伤。酒进入人体后,酒精被吸收入血,随饮酒量的增加血中酒精浓度也相应增加,当血中酒精浓度达到0.5%以上时,可出现高度抑制、昏睡、意识障碍、大小便失禁,如不进行及时抢救,可因呼吸麻痹而死亡。因此对于饮酒过度的人来说,非常需要有一种解酒药物来缓解和治疗其酒精中毒。目前临床上尚没有一种疗效确切的解酒药供医生选择使用。Drinking alcohol is a hobby of most people, but excessive drinking can cause serious damage to the human body. After alcohol enters the human body, the alcohol is absorbed into the blood, and the alcohol concentration in the blood also increases correspondingly with the increase of the amount of drinking. When the alcohol concentration in the blood reaches more than 0.5%, high depression, drowsiness, disturbance of consciousness, and incontinence may occur, such as If timely rescue is not carried out, death may occur due to respiratory paralysis. Therefore for people who drink excessively, it is very necessary to have a kind of anti-alcoholic medicine to alleviate and treat its alcoholism. At present, there is not yet a kind of definite anti-alcoholic medicine for doctors to choose and use clinically.

本发明目的是提供一种解酒药物制剂。The object of the present invention is to provide a drug preparation for anti-alcoholism.

本发明的另一个目的是提供上述解酒制剂的加工工艺。Another object of the present invention is to provide a processing technology for the above-mentioned anti-alcohol preparation.

本发明解酒药剂的组方及制备过程如下:The prescription and the preparation process of the anti-alcoholic medicament of the present invention are as follows:

处方组成:葛花、青皮、人参茎叶皂甙。Prescription composition: kudzu flower, green bark, ginseng stem and leaf saponin.

上述处方中各组份的用量比为(重量比):The consumption ratio of each component in the above-mentioned prescription is (weight ratio):

葛花∶青皮∶人参茎叶皂甙=25-35∶5-15∶0.5-2。Pueraria japonica: green bark: ginseng stem and leaf saponin=25-35:5-15:0.5-2.

各组份之间的最佳重量比为:The optimal weight ratio between each component is:

葛花∶青皮∶人参茎叶皂甙=30∶10∶1。Pueraria japonica: green bark: ginseng stem and leaf saponins = 30:10:1.

上述处方中使用的人参茎叶皂甙是从人参茎叶中提取的呈浅棕色粉末,具有吸湿性的皂甙提取物〔参见:《药学学报》1983年第18卷第10期〕。本发明使用的人参茎叶皂甙应符合辽卫药准字(84)942-66号《关于人参皂甙暂行质量标准的批复》批文的质量要求。The ginseng stem and leaf saponin used in the above prescription is a light brown powder extracted from the ginseng stem and leaf, and is a saponin extract with hygroscopicity [refer to: "Acta Pharmacologica" 1983, Volume 18, No. 10]. The ginseng stem and leaf saponins used in the present invention should meet the quality requirements of the approval document No. (84) 942-66 "Reply on Interim Quality Standards for Ginsenosides".

在实际制剂过程中,上述处方还可加入常规的药物赋形剂,如淀粉、糊精等。赋形剂的加入量对于药效的影响并不是至关重要的,本领域中的技术人员可根据实际需要而选择其常用量。In the actual preparation process, conventional pharmaceutical excipients, such as starch and dextrin, can also be added to the above prescription. The amount of excipients added is not critical to the effect of the drug, and those skilled in the art can choose the usual amount according to actual needs.

上述的药物组合物可以制备成不同的剂型,如冲剂、茶剂、片剂、胶囊剂、口服液等。The above-mentioned pharmaceutical composition can be prepared into different dosage forms, such as electuary, tea, tablet, capsule, oral liquid and the like.

现结合胶囊剂型说明其加工工艺过程。Now combine the capsule dosage form to illustrate its processing technology.

二、制备工艺2. Preparation process

(一)工艺流程(1) Process flow

原料→煎煮→过滤→浓缩→加入人参皂甙→干燥→粉碎→过筛→加适量淀粉混匀→装胶囊→包装。Raw materials→decocting→filtering→concentrating→adding ginsenosides→drying→crushing→sieving→adding appropriate amount of starch and mixing→filling in capsules→packing.

(二)操作过程(2) Operation process

按处方组成中的原料量,称取葛花和青皮用12倍水润湿后加热煮沸1小时沙布过滤。药渣再加入7-8倍水煮沸40分钟,按上法过滤。合并滤液,减压浓缩至稀糊状,加入处方量人参茎叶皂甙,60-80℃下减压干燥。干燥物粉碎后过80目筛,干粉加适量淀粉混匀装入胶囊中,囊心物均在0.48克左右。According to the amount of raw materials in the composition of the prescription, weigh Pueraria japonica and Qingpi, moisten with 12 times of water, heat and boil for 1 hour and filter with gauze. Add 7-8 times of water to the dregs, boil for 40 minutes, and filter according to the above method. Combine the filtrates, concentrate under reduced pressure to a thin paste, add the prescribed amount of ginseng stem and leaf saponins, and dry under reduced pressure at 60-80°C. The dry matter is crushed and passed through an 80-mesh sieve, and the dry powder is mixed with an appropriate amount of starch and packed into capsules, and the capsule core is about 0.48 grams.

(三)工艺说明(3) Process Description

1.用煎煮法进行提取的依据1. The basis for extraction by decoction

本方中葛花为君药。葛花中的主要醒酒有效成份为水溶性成份,故用水煎法可以更好的发挥药效。青皮中的主要有效成份为黄酮甙类化合物,在热水中也有较好的溶解度,故本处方的提取采用水煎法。In this prescription, Pueraria lobata is the monarch drug. The main sobering active ingredients in kudzu flower are water-soluble ingredients, so decoction with water can better exert the medicinal effect. The main active ingredients in Qingpi are flavonoid glycosides, which also have good solubility in hot water, so the extraction of this prescription adopts the water decoction method.

2.煎煮时间的考查2. Examination of cooking time

本处方主要成分葛花和青皮,它们均分别含有异黄酮和二氢黄酮,在UV中270nm附近有最大吸收,可以作为主要成分来考查提取工艺。总提取物的UV吸收光谱见附图。The main ingredients of this prescription are Pueraria japonica and Qingpi. They both contain isoflavones and flavanones respectively, and have the maximum absorption near 270nm in UV, which can be used as the main ingredients to examine the extraction process. The UV absorption spectrum of the total extract is shown in the accompanying drawing.

按处方量投料后共提取三次,从沸腾时间算起每隔20分钟取样,在275nm处测定紫外吸收度,数值见表1及图1。图1为溶出速率曲线。After feeding according to the prescription amount, extract three times in total, take samples every 20 minutes from the boiling time, and measure the UV absorbance at 275nm, the values are shown in Table 1 and Figure 1. Figure 1 is the dissolution rate curve.

表1提取次数及提取百分率的实验结果The experimental result of table 1 extraction number of times and extraction percentage 提取次数 Extraction times 1 1 2 2 3 3 各次提取液平衡时的吸收度 The absorbance of each extraction solution at equilibrium 0.51 0.51 0.21 0.21 0.10 0.10 提取百分率(%) Extraction percentage (%) 64.8 64.8 23.9 23.9 11.4 11.4

结论        从上表及图示的实验结果可以得出下列结论:Conclusion The following conclusions can be drawn from the experimental results in the above table and diagrams:

(1)、第一次煎煮提取时以1小时为宜。因为在第一次提取时吸收度在60分钟已达到平衡不再升高,说明已达到最大提取率,应重新更新溶剂。(1) It is advisable to decoct and extract for the first time for 1 hour. Because the absorbance has reached equilibrium in 60 minutes during the first extraction and no longer increases, indicating that the maximum extraction rate has been reached, and the solvent should be renewed.

(2)、第二次煎煮提取时,提取吸收度在40分钟后不再改变,亦说明提取较完全。(2) When decocting and extracting for the second time, the extraction absorbency does not change after 40 minutes, which also shows that the extraction is relatively complete.

3.煎煮次数的决定3. Determination of the number of times of decoction

按处方量投料后共提取三次,测定紫处吸收度。表二所示的吸收度代表提取率。则第一、二、三煎的提取率分别为64.8%、23.9%及11.4%。其中第一、二煎占总提取率的88.7%,已将生药中有效成分绝大部分提取出来,故考虑到成本及能源消耗等诸因素确定只提取两次。After feeding according to the prescription amount, it was extracted three times in total, and the absorbance of purple part was measured. The absorbance shown in Table 2 represents the extraction rate. The extraction rates of the first, second and third decoctions are 64.8%, 23.9% and 11.4% respectively. Among them, the first and second decoctions account for 88.7% of the total extraction rate, and most of the active ingredients in the crude drug have been extracted, so it is determined to only extract twice in consideration of various factors such as cost and energy consumption.

4.出膏率的考查:4. Examination of the ointment rate:

我们共进行了三批原料出膏率的考查,两次提取液浓缩后浸膏收率为17%→20%左右。结果见下表:We conducted a total of three batches of raw materials to examine the yield of the extract, and the yield of the extract was about 17%→20% after the two extractions were concentrated. The results are shown in the table below:

批号 batch number 投料量(g) Feed amount (g) 浸膏量(g) Amount of extract (g) 出膏率(%) Paste yield (%) 920417 920417 240 240 40 40 16.7 16.7 920418 920418 240 240 42 42 17.5 17.5 920419 920419 240 240 47 47 19.6 19.6

本发明的解酒药物具有良好的解酒、醒酒功能。通过滚棒实验和苏醒试验表明时,本发明药物具有较好的抗急性酒精中毒的能力,并且明显延迟动物开始醉酒的时间,并缩短动物的昏睡时。是一种效果肯定的解酒药。The anti-alcoholic drug of the invention has good anti-alcoholic and sober functions. When it is shown by rolling rod test and recovery test, the medicament of the present invention has better anti-acute alcoholism ability, and obviously delays the time for animals to start getting drunk, and shortens the animals' drowsiness. It is a definite anti-alcoholic medicine.

实施例1Example 1

取葛花1500g,青皮500g,加12倍水浸润后加热煮沸1小时,沙布过滤,药渣再加7-8倍水煮沸40分钟,再用沙布过滤,合并滤液,减压浓缩至稀糊状,加入人参茎叶皂甙50g,60-80℃下减压干燥,干燥物粉碎后过80目筛,加适量淀粉混匀共500g,装入胶囊中,囊物在0.5g左右。Take 1500g of kudzu flower and 500g of green skin, add 12 times of water to infiltrate, heat and boil for 1 hour, filter with gauze, add 7-8 times of water to the dregs and boil for 40 minutes, then filter with gauze, combine the filtrates, concentrate under reduced pressure to dilute Paste, add 50g of ginseng stem and leaf saponins, dry under reduced pressure at 60-80°C, crush the dry matter and pass through an 80-mesh sieve, add an appropriate amount of starch and mix to make a total of 500g, put it into a capsule, and the capsule content is about 0.5g.

Claims (9)

1、一种解酒的药物组合物,其特征在于它由下列组份组成:葛花、青皮、人参茎叶皂甙,各组份之间的重量比是葛花∶青皮∶人参茎叶皂甙=25-35∶5-15∶0.5-2。1. A medicinal composition for hangover, characterized in that it is made up of the following components: kudzu flower, green bark, ginseng stem and leaf saponin, and the weight ratio between each component is kudzu flower: green bark: ginseng stem and leaf saponin= 25-35:5-15:0.5-2. 2、根据权利要求1的药物组合物,其特征在于各组份之间的重量比为:2. The pharmaceutical composition according to claim 1, characterized in that the weight ratio between the components is: 葛花∶青皮∶人参茎叶皂甙=30∶10∶1。Pueraria japonica: green bark: ginseng stem and leaf saponins = 30:10:1. 3、根据权利要求1的药物组合物,其特征在于还可以加入药学上可接受的赋形剂。3. The pharmaceutical composition according to claim 1, characterized in that pharmaceutically acceptable excipients can also be added. 4、根据权利要求3的药物组合物,其特征在于所说的赋形剂是淀粉。4. Pharmaceutical composition according to claim 3, characterized in that said excipient is starch. 5、一种解酒药物组合物的制备方法,其特征在于以葛花、青皮、人参茎叶皂甙=0.5-35∶5-15∶0.5-2(重量比)为原料,先将葛花、青皮加水煎煮,过滤浓缩,加入人参皂甙,干燥粉碎,过筛,加适量淀粉混匀,制成药用剂型。5. A preparation method of a hangover medicinal composition, which is characterized in that kudzu flower, green bark, ginseng stem and leaf saponin=0.5-35:5-15:0.5-2 (weight ratio) are used as raw materials, first kudzu flower, Add water to decoct green bark, filter and concentrate, add ginsenoside, dry and pulverize, sieve, add appropriate amount of starch and mix well to make medicinal dosage form. 6、根据权利要求5的制备方法,其特征在于称取葛花和青皮用12倍水润湿后加热煮沸1小时沙布过滤,药渣再加入7-8倍水煮沸40分钟,按上法过滤,合并滤液,减压浓缩至稀糊状,加入处方量人参茎叶皂甙,60-80℃下减压干燥,干燥物粉碎后过80目筛,干粉加适量淀粉混匀,制成药用剂型。6, according to the preparation method of claim 5, it is characterized in that take kudzu flower and Qingpi and moisten with 12 times of water, heat and boil for 1 hour and filter with gauze, add 7-8 times of water to the dregs and boil for 40 minutes, according to the above method Filtrate, combine the filtrates, concentrate under reduced pressure to a thin paste, add the prescribed amount of ginseng stem and leaf saponins, dry under reduced pressure at 60-80°C, crush the dry matter and pass through an 80-mesh sieve, add an appropriate amount of starch to the dry powder and mix well, and make it into a medicinal product dosage form. 7、根据权利要求6的制备方法,所说的药用剂型是胶囊剂、片剂和冲剂。7. The preparation method according to claim 6, said pharmaceutical dosage forms are capsules, tablets and granules. 8、根据权利要求6的制备方法,所说的药用剂型是茶剂。8. The preparation method according to claim 6, said pharmaceutical dosage form is tea. 9、根据权利要求6的制备方法,其特征在于所说的剂型是口服液。9. The preparation method according to claim 6, characterized in that said dosage form is oral liquid.
CN 93107382 1993-06-28 1993-06-28 A kind of anti-alcoholic health care medicinal composition Pending CN1080863A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 93107382 CN1080863A (en) 1993-06-28 1993-06-28 A kind of anti-alcoholic health care medicinal composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 93107382 CN1080863A (en) 1993-06-28 1993-06-28 A kind of anti-alcoholic health care medicinal composition

Publications (1)

Publication Number Publication Date
CN1080863A true CN1080863A (en) 1994-01-19

Family

ID=4986666

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 93107382 Pending CN1080863A (en) 1993-06-28 1993-06-28 A kind of anti-alcoholic health care medicinal composition

Country Status (1)

Country Link
CN (1) CN1080863A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1055211C (en) * 1994-04-07 2000-08-09 任贵兴 Antialcoholic liver-protecting preparation and its preparing method
US6399072B1 (en) * 1996-03-13 2002-06-04 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of alcoholism
US6509381B2 (en) * 1996-03-13 2003-01-21 Archer Daniels Midland Company Method of preparing and using compositions extracted from vegetable matter for the treatment of neurological conditions
CN103461871A (en) * 2013-07-29 2013-12-25 安徽燕之坊食品有限公司 Sobering-up foodstuff and preparation method thereof
CN111956713A (en) * 2020-09-03 2020-11-20 华熙生物科技股份有限公司 Hangover-alleviating and liver-protecting composition containing hyaluronic acid and application thereof
CN121059699A (en) * 2025-10-31 2025-12-05 内蒙古医科大学附属医院(内蒙古自治区心血管研究所) Traditional Chinese medicine compositions, preparation methods, and applications with hangover-relieving and liver-protecting effects.

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1055211C (en) * 1994-04-07 2000-08-09 任贵兴 Antialcoholic liver-protecting preparation and its preparing method
US6399072B1 (en) * 1996-03-13 2002-06-04 Archer Daniels Midland Company Method of preparing and using isoflavones for the treatment of alcoholism
US6509381B2 (en) * 1996-03-13 2003-01-21 Archer Daniels Midland Company Method of preparing and using compositions extracted from vegetable matter for the treatment of neurological conditions
US6518319B1 (en) * 1996-03-13 2003-02-11 Archer Daniels Midland Company Method of preparing and using compositions extracted from vegetable matter for the treatment of female symptoms
US6900240B2 (en) 1996-03-13 2005-05-31 Archer-Daniels-Midland Company Method of preparing and using compositions extracted from vegetable matter for the treatment of cancer
CN103461871A (en) * 2013-07-29 2013-12-25 安徽燕之坊食品有限公司 Sobering-up foodstuff and preparation method thereof
CN111956713A (en) * 2020-09-03 2020-11-20 华熙生物科技股份有限公司 Hangover-alleviating and liver-protecting composition containing hyaluronic acid and application thereof
CN111956713B (en) * 2020-09-03 2021-10-15 华熙生物科技股份有限公司 Hangover-alleviating and liver-protecting composition containing hyaluronic acid and application thereof
CN121059699A (en) * 2025-10-31 2025-12-05 内蒙古医科大学附属医院(内蒙古自治区心血管研究所) Traditional Chinese medicine compositions, preparation methods, and applications with hangover-relieving and liver-protecting effects.

Similar Documents

Publication Publication Date Title
CN102100874A (en) A kind of Chinese patent medicine for treating diabetes and preparation method thereof
CN107412721B (en) A kind of hypoglycemic bitter gourd polypeptide compound capsule and preparation method thereof
CN100542584C (en) Compound seabuckthorn buccal tablet and preparation method thereof
CN102302673B (en) Traditional Chinese medicine compound preparation for preventing and treating diabetic nephropathy (DN)
CN110876772A (en) Preparation method and application of traditional Chinese medicine preparation with liver protection function
CN102614281A (en) Chinese medicinal composition for improving anoxia endurance and preparation method and application thereof
CN1080863A (en) A kind of anti-alcoholic health care medicinal composition
CN1292671C (en) Method for producing tu-chung instant tea and its water drinking product
CN107801990A (en) A kind of health food of auxiliary hyperglycemic and preparation method thereof
CN1080864A (en) A kind of alcohol-decomposing powder and preparation method thereof
CN111298021A (en) Traditional Chinese medicine composition for treating functional constipation
CN101642480A (en) Pseudo-ginseng flower leaf oral tablet with function of reducing fever and preparation method thereof
CN108977326A (en) A kind of notoginsen flower wine and its preparation process
CN108324803A (en) Solid beverage of auxiliary hyperglycemic and preparation method thereof
CN106106945A (en) A kind of Ganoderma bagged infusion of American ginseng tea of enhancing immunity and preparation method thereof
CN107595954A (en) A traditional Chinese medicine composition for reducing body fat mass and treating abdominal obesity and its application
CN113952419A (en) Pharmaceutical composition for chronic renal failure and preparation method and application thereof
CN101020016B (en) Medicine for treating fracture and injured tendon and its preparation
CN106177416B (en) A kind of Chinese medicine composition for lowering blood sugar and preparation method thereof
CN101011550A (en) Medicinal composition for relieving stagnation, promoting circulation of qi and relieving pain, and its preparing process
CN101147767B (en) Preparation method of medicinal composition for treating acne
LU600020B1 (en) A traditional Chinese medicine composition for the treatment of alcoholic liver disease and its manufacturing process
LU503014B1 (en) BRAIN-TONIFYING GRANULES AND PREPARATION METHOD THEREOF
CN114425066B (en) Composition, medicine, food or health product for relieving physical fatigue and preparation method thereof
CN102657699B (en) Cane sugar-containing and sugar-free Shenkun blood nourishing granules with longer period of validity

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication